Sardocor, a subsidiary wholly-owned by Medera (www.linkedin.com/company/medera-biopharmaceutical), is dedicated to the clinical development of novel therapies.

Building upon Novoheart’s (www.linkedin.com/company/novoheart-limited) bioengineered human tissue-based assays for disease modelling and drug discovery, Sardocor aspires to create the shortest regulatory path to the clinic for advancing effective next-generation cell & gene therapy

Therapeutics

Sardocor

Org chart

Similar companies